Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites

Obstetrics and Gynecology

Volumn 109, Issue 6, 2007, Pages 1358-1367

  Read, Jennifer S ^a   Cahn, Pedro ^b   Losso, Marcelo ^b   Pinto, Jorge ^b   Joao, Esau ^b   Duarte, Geraldo ^b   Cardoso, Edmundo ^b   Freimanis Hance, Laura ^b   Stoszek, Sonia K ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARGENTINA; ARTICLE; BAHAMAS; BRAZIL; BREAST FEEDING; CENTRAL AMERICA; CESAREAN SECTION; CHEMOPROPHYLAXIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONCEPTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABOR; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEMBRANE RUPTURE; MEXICO; MOTHER; NEWBORN; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SOUTH AND CENTRAL AMERICA; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BREAST FEEDING; CARIBBEAN REGION; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; LATIN AMERICA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 34249910616     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000265211.76196.ac     Document Type: Article

References (18)

1. Read JS. Prevention of mother-to-child transmission of HIV. In: Zeichner SL, Read JS, editors. Textbook of pediatric HIV care. New York (NY): Cambridge University Press; 2005. p. 111-33.
2. U.S. Department of Health and Human Services. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States-October 12, 2006. Available at: http://www. aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search= Off&GuidelineID=9&ClassID=2. Retrieved March 27, 2007.
3. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
4. Ministry of Health and Environment of the Nation, National Directorate of Maternal and Infant Health, Maternal and Infant Program of the Buenos Aires Province and the Directorate of Information of the Province of Neuquén. Nutri Program, Developed in EpiInfo: http://www.msal.gov.ar/htm/Site/promin/ UCMISALUD/Software/nutri13.zip [in Spanish]. Available at: http://www.msal.gov. ar/htm/Site/promin/UCMISALUD/utilidades/util.htm. Retrieved September 18, 2006
5. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents - October 10, 2006. Available at: http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL.pdf. Retrieved February 7, 2007.)
6. Yamashita TE, Phair JP, Munoz A, Margolick JB, Detels R, O'Brien SJ, et al. Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS 2001;15:735-746.
7. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991;119:417-23.
8. Dubowitz LM, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970;77:1-10.
9. Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978;93:120-2.
10. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951;38:141-9.
11. Recomendaciones sobre tratamiento antiretroviral 2003/2004. Buenos Aires (Argentina): Sociedad Argentina de Infectología, Comisión de SIDA; 2006. Available at: http://www.msal.gov.ar/htm/site/Lusida/RecomTerap/ Recomendaciones-tratamientohiv-adultos.pdf. Retrieved March 27, 2007.
12. Recomendações para profilaxia da transmissão vertical do HIV e terapia anti-retroviral em gestantes. Brasilia (Brazil): Ministerio da Saude, Secretaria de Vigilancia em Saude, Programa Nacional de DST/AIDS, Brasil; 2006. Available at: http://www.aids.gov.br/final/tratamento/gestante2.pdf. Retrieved March 27, 2007.
13. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. [published erratum appears in Lancet 1999;353:1714]. Lancet 1999;353:1035-9.
14. The International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of Human Immunodeficiency Virus type 1: a meta-analysis from fifteen prospective cohort studies. AIDS 2001;15:357-68.
15. Ryder RW, Temmerman M. The effect of HIV-1 infection during pregnancy and the perinatal period on maternal and child health in Africa. AIDS 1991;5:S75-85.
16. Temmerman M, Chomba EN, Piot P. HIV-1 and reproductive health in Africa. Int J Gynecol Obstet 1994;44:107-12.
17. Leroy V, Ladner J, Nyiraziraje M, De Clercq A, Bazubagira A, Van de Perre P, et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS 1998;12:643-50.
18. Markson LE, Turner BJ, Houchens R, Silverman NS, Cosler L, Takyi BK. Association of maternal HIV infection with low birth weight. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:227-34.